Lecture 21: Lipoproteins Flashcards
1
Q
Triglyceride formation
A
- Triglycerides are made starting with phosphatidate
- Phosphate is first removed by a phosphatase producing diacylglycerol
- Diacylglycerol acyltransferase adds 3rd fatty acyl tail to make triacylglyceride
- Elevated insulin promotes activation of all enzymes involved(ACC, FAS, and acyltransferases)
- TAGs produced in liver can be released into blood stream as lipoproteins
2
Q
Lipoproteins
A
- Lipoproteins are transport molecules for hydrophobic TAGs and cholesterol esters throughout the body
- Thin monolayer of phospholipids and cholesterol
- Polar portions of molecules face aqueous exterior, while hydrophobic ones face hydrophobic interior
- Apoproteins are on surface of lipoproteins and are oriented with hydrophilic side chain outwards and hydrophobic side chains inwards
3
Q
Cholesterol Metabolism
A
- Cholesterol is crucial for membranes and is metabolized to produce hormones and vitamin D3
- Cholesterol is made from acetyl-coA in cytoplasm of liver cells using carbons from fat/protein/carbohydrate catabolism
- Cholesterol can be modified to a hydrophobic acyl-carrying molecule called a cholesterol ester by acyltransferases
- Production of cholesterol requires NADPH and ATP and is regulated by inhibiting an enzyme called HMG-CoA reductase
4
Q
How does exercise lead to inhibition of HMG-CoA reductase
A
- Epinephrine released -> activate PKA -> phosphorylate HMG-CoA reductase -> no cholesterol synthesis
5
Q
Lipid Transport via Lipoproteins
A
- Lipoproteins are made in the liver or intestine
- As they travel through the body, fatty acids and cholesterol are transferred to tissues to produce energy, build membranes, or produce other molecules
- Whatever doesn’t get used returns to liver as lipoprotein remnants for recycling. Additional cholesterol and TAGs are synthesized for the production of new lipoproteins
- Excess synthesis of fats, defects in the receptors that recycle lipoproteins, or problems with the activity of HMG-CoA Reductase can disrupt the balance of lipid metabolism and lead to high cholesterol and cardiovascular disease
6
Q
Lipo-proteins
A
- Different lipoproteins can be differentiated by their individual components(apoproteins, % TAGs, % cholesterol)
- Chylomicrons are made in the small intestine from the diet and are the largest and contain an apoprotein known as apoprotein 48
- Very Low Density Lipoprotein(VLDL) is made by liver and contains the ApoB100 protein
- Lipoprotein lipase attacks VLDL to hydrolyze TAGs and produce Intermediate Density Lipoprotein(IDL) and then Low Density Lipoprotein(LDL)
- High Density Lipoprotein(HDL) is good cholesterol that picks up cholesterol and transports them back to liver for breakdown and recycling
7
Q
Lipoprotein Metabolism in Circulation
A
- Apoproteins help with targeting and binding to cells and other proteins via non-covalent interactions
- Membrane-bound enzymes help release free fatty acids for cellular use
8
Q
Lipoprotein Classification
A
- HDL is known as good cholesterol: travels through the body and picks up cholesterol esters using a lecithin cholesterol acyl transferase enzyme; returns remaining cholesterol to liver for processing and breakdown
9
Q
Cholesterol and Cardiovascular Disease
A
- Cholesterol is found in the diet but is also synthesized in the liver
- The liver is responsible for monitoring cholesterol levels and for lipoprotein recycling and the synthesis of new cholesterol
- Increased cholesterol intake, synthesis in liver, or decreased lipid turnover and use can lead to cardiovascular disease
- Oxidized LDL particles have been found to be principal components in arterial plaques resulting in heart attack or stroke
- Macrophages can’t break down oxidized LDL
10
Q
Improving cardiovascular health
A
- Exercise and proper diet can help increase HDL and lower LDL levels
- Proper diet includes monitoring fat intake(decrease trans and saturated fat) but also caloric intake
- Decrease stress to lower blood pressure and prevent arterial damage where oxidized LDL accumulates
11
Q
Omega-3 fatty acids
A
- Omega 3 fatty acid intake have been associated with:
- Reduced VLDL synthesis
- Reduced availability of FA chains for TAG synthesis
- Increased phospholipid synthesis
- Increased beta-oxidation
- Reduced hepatic ACC and FAS enzyme activity